CE- Antithrombotic Therapy for Symptomatic PAD: Interpreting the Evidence and Recent Advances
Posted almost 3 years ago by Rick Ramirez in Education
Aloha all,
Please see below for this great learning opportunity
Mahalo,
The Education Committee
Making Education HAPN
| View Web Version |
   
|
| Antithrombotic Therapy for Symptomatic PAD: Interpreting the Evidence and Recent Advances |
 |
| Explore Clinical Implications With Expert Faculty |
| Patients with diabetes and PAD, particularly those with concomitant polyvascular disease, are at a greater risk for future adverse cardiovascular and limb events. Furthermore, peripheral revascularization has become increasingly common in PAD patients, however, patients who undergo this procedure are still at an increased risk for future adverse events, particularly for acute limb ischemia. Given these heightened risks in PAD patients with cardiometabolic disease or risk, traditional antiplatelet strategies may not be adequate. Several clinical trials have been recently concluded or ongoing that have evaluated novel antithrombotic therapy in this setting, and these advances and their clinical practice implications will be covered during this symposium by expert faculty. This activity is part of the PAD Digital Highlights Hub. Earn 1.00 / AMA PRA Category 1 Credit™, 1.00 / ABIM MOC Part II Point, 1.00 / CNE Contact Hour, 1.00 / CE for Pharmacists, or 1.00 / CPEU Credit. |
| Begin Activity ► |
| FACULTY |
|
Deepak L. Bhatt, MD (Chair) Marc P. Bonaca, MD Manesh R. Patel, MD |
| CLICK HERE TO START NOW |